-
-
-
-
-
-
-
K2 Capital Acquisition Corporation Announces Pricing of Upsized $120 Million Initial Public Offering
-
-
-
-
-
-
-
K2M Receives FDA Clearance Including Surgical Guidance that Enhances MESA® Platform Using Patient-Specific Rods & Rails
-
-
-
-
-
-
-
Oppenheimer Downgrades K2M Group Holdings (KTWO) to Perform
-
-
-
-
-
-
-
K2M Group Holdings, Inc. Announces Definitive Agreement To Be Acquired by Stryker Corporation
-
-
-
-
-
-
-
K2M to Showcase 3D Spinal Balance Portfolio and Balance ACS® Platform at IMAST 2018
-
-
-
-
-
-
-
K2M Group Holdings, Inc. Announces Pricing of Private Offering of $65.0 Million Aggregate Principal Amount of 3.00% Convertible Senior Notes due 2025
-
-
-
-
-
-
-
K2M Receives FDA Clearance for BACS® Patient-Specific Module
-
1,160,145 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

